Bone Health

Latest News

EU flag | Image credit: Ivan - stock.adobe.com
EC Approves Celltrion Denosumab, Aflibercept Biosimilars

February 20th 2025

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar (Eydenzelt).

bone fracture | Image credit: eddows - stock.adobe.com
FDA, EMA Approve Second Pair of Denosumab Biosimilars

February 17th 2025

Osteoporosis. | Image Credit: mat - stock.adobe.com
Teriparatide Biosimilar Shows Comparable Efficacy to Reference Drug in Postmenopausal Osteoporosis

February 17th 2025

broken arm | Image credit: eddows - stock.adobe.com
Biosimilar Teriparatide Matches Forteo in Safety and Fracture Risk

January 23rd 2025

FDA logo | Image credit: Rafael Henrique - stock.adobe.com
A Banner Year for Biosimilars: The 19 FDA Approvals From 2024

January 21st 2025

Podcasts
CFB podcast banner
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.